Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Assessing direct and indirect effects of pediatric influenza vaccination in Germany by individual-based simulations.

Schmidt-Ott R, Molnar D, Anastassopoulou A, Yanni E, Krumm C, Bekkat-Berkani R, Dos Santos G, Henneke P, Knuf M, Schwehm M, Eichner M.

Hum Vaccin Immunother. 2019 Dec 6:1-10. doi: 10.1080/21645515.2019.1682843. [Epub ahead of print]

PMID:
31647348
2.

Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines.

Esposito S, Stefanelli P, Fry NK, Fedele G, He Q, Paterson P, Tan T, Knuf M, Rodrigo C, Weil Olivier C, Flanagan KL, Hung I, Lutsar I, Edwards K, O'Ryan M, Principi N; World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Vaccine Study Group of the European Society of Clinical Microbiology and Infectious Diseases (EVASG).

Front Immunol. 2019 Jul 3;10:1344. doi: 10.3389/fimmu.2019.01344. eCollection 2019. Review.

3.

A DELPHI study on aspects of study design to overcome knowledge gaps on the burden of disease caused by serogroup B invasive meningococcal disease.

Marten O, Koerber F, Bloom D, Bullinger M, Buysse C, Christensen H, De Wals P, Dohna-Schwake C, Henneke P, Kirchner M, Knuf M, Lawrenz B, Monteiro AL, Sevilla JP, Van de Velde N, Welte R, Wright C, Greiner W.

Health Qual Life Outcomes. 2019 May 22;17(1):87. doi: 10.1186/s12955-019-1159-0.

4.

Immunogenicity and safety of meningococcal group A, C, W and Y tetanus toxoid conjugate vaccine: review of clinical and real-world evidence.

Findlow J, Knuf M.

Future Microbiol. 2019 May;14:563-580. doi: 10.2217/fmb-2018-0343. Epub 2019 May 16. Review.

PMID:
31091978
5.

Neue Entwicklungen bei Impfstoffen für Kinder und Jugendliche.

Knuf M, Zepp F.

Drug Res (Stuttg). 2018 Nov;68(S 01):S27-S29. doi: 10.1055/a-0733-1078. Epub 2018 Nov 19. German. No abstract available.

PMID:
30453374
6.

Neurologic phenotypes associated with COL4A1/2 mutations: Expanding the spectrum of disease.

Zagaglia S, Selch C, Nisevic JR, Mei D, Michalak Z, Hernandez-Hernandez L, Krithika S, Vezyroglou K, Varadkar SM, Pepler A, Biskup S, Leão M, Gärtner J, Merkenschlager A, Jaksch M, Møller RS, Gardella E, Kristiansen BS, Hansen LK, Vari MS, Helbig KL, Desai S, Smith-Hicks CL, Hino-Fukuyo N, Talvik T, Laugesaar R, Ilves P, Õunap K, Körber I, Hartlieb T, Kudernatsch M, Winkler P, Schimmel M, Hasse A, Knuf M, Heinemeyer J, Makowski C, Ghedia S, Subramanian GM, Striano P, Thomas RH, Micallef C, Thom M, Werring DJ, Kluger GJ, Cross JH, Guerrini R, Balestrini S, Sisodiya SM.

Neurology. 2018 Nov 27;91(22):e2078-e2088. doi: 10.1212/WNL.0000000000006567. Epub 2018 Nov 9.

7.

High antibiotic prescription rates in hospitalized children with human metapneumovirus infection in comparison to RSV infection emphasize the value of point-of-care diagnostics.

Schreiner D, Groendahl B, Puppe W, Off HNT, Poplawska K, Knuf M, Meyer CU, Reischl AT, Gehring S.

Infection. 2019 Apr;47(2):201-207. doi: 10.1007/s15010-018-1194-5. Epub 2018 Aug 21.

PMID:
30132249
8.

Antibody persistence and booster response 68 months after vaccination at 2-10 years of age with one dose of MenACWY-TT conjugate vaccine.

Knuf M, Helm K, Kolhe D, Van Der Wielen M, Baine Y.

Vaccine. 2018 May 31;36(23):3286-3295. doi: 10.1016/j.vaccine.2018.04.064. Epub 2018 Apr 30.

9.

Stand-alone craniocervical decompression is feasible in children with mucopolysaccharidosis type I, IVA, and VI.

Krenzlin H, Ta-Chih T, Lampe C, Lampe C, Knuf M, Horn P, Schwarz M.

Spine J. 2018 Aug;18(8):1455-1459. doi: 10.1016/j.spinee.2018.04.002. Epub 2018 Apr 9.

PMID:
29649608
10.

Correlation of morphological parameters and visual acuity with neurological development in former preterm children aged 4-10 years.

Fieß A, Kölb-Keerl R, Schuster AK, Knuf M, Kirchhof B, Muether PS, Bauer J.

Acta Ophthalmol. 2018 Dec;96(8):e1010-e1017. doi: 10.1111/aos.13755. Epub 2018 Mar 9.

11.

Immunization of preterm infants with GSK's hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: A review of safety and immunogenicity.

Omeñaca F, Vázquez L, Garcia-Corbeira P, Mesaros N, Hanssens L, Dolhain J, Puente Gómez I, Liese J, Knuf M.

Vaccine. 2018 Feb 8;36(7):986-996. doi: 10.1016/j.vaccine.2018.01.005. Epub 2018 Jan 12. Review.

12.

Corneal Aberrations in Former Preterm Infants: Results From The Wiesbaden Prematurity Study.

Fieß A, Schuster AK, Kölb-Keerl R, Knuf M, Kirchhof B, Muether PS, Bauer J; Prematurity Eye Study Group.

Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6374-6378. doi: 10.1167/iovs.17-22895.

PMID:
29260194
13.

Prevalence and associated factors of strabismus in former preterm and full-term infants between 4 and 10 Years of age.

Fieß A, Kölb-Keerl R, Schuster AK, Knuf M, Kirchhof B, Muether PS, Bauer J.

BMC Ophthalmol. 2017 Dec 2;17(1):228. doi: 10.1186/s12886-017-0605-1.

14.

[Evaluation of Ophthalmic Follow-up Care of Former Pre-term and Full-term Infants Aged from 4 to 10 Years in Germany - Results of the Wiesbaden Prematurity Study (WPS)].

Fieß A, Kölb-Keerl R, Elflein HM, Schuster AK, Knuf M, Kirchhof B, Oberacher-Velten I, Muether PS, Bauer J.

Klin Monbl Augenheilkd. 2019 Oct;236(10):1174-1181. doi: 10.1055/s-0043-118852. Epub 2017 Nov 8. German.

PMID:
29117610
15.

MMR and MMRV vaccines.

Kowalzik F, Faber J, Knuf M.

Vaccine. 2018 Aug 28;36(36):5402-5407. doi: 10.1016/j.vaccine.2017.07.051. Epub 2017 Jul 27. Review.

PMID:
28757060
16.

Macular morphology in former preterm and full-term infants aged 4 to 10 years.

Fieß A, Janz J, Schuster AK, Kölb-Keerl R, Knuf M, Kirchhof B, Muether PS, Bauer J.

Graefes Arch Clin Exp Ophthalmol. 2017 Jul;255(7):1433-1442. doi: 10.1007/s00417-017-3662-5. Epub 2017 Apr 25.

PMID:
28439729
17.

Axial Length and Anterior Segment Alterations in Former Preterm Infants and Full-Term Neonates Analyzed With Scheimpflug Imaging.

Fieß A, Kölb-Keerl R, Knuf M, Kirchhof B, Blecha C, Oberacher-Velten I, Muether PS, Bauer J.

Cornea. 2017 Jul;36(7):821-827. doi: 10.1097/ICO.0000000000001186.

PMID:
28437274
18.

Functional analysis and associated factors of the peripapillary retinal nerve fibre layer in former preterm and full-term infants.

Fieß A, Christian L, Janz J, Kölb-Keerl R, Knuf M, Kirchhof B, Muether PS, Bauer J; Prematurity Eye Study Group.

Br J Ophthalmol. 2017 Oct;101(10):1405-1411. doi: 10.1136/bjophthalmol-2016-309622. Epub 2017 Mar 8.

PMID:
28274943
19.

Peripapillary Choroidal Thickness in Former Preterm and Full-Term Infants Aged From 4 to 10 Years.

Fieß A, Christian L, Kölb-Keerl R, Knuf M, Kirchhof B, Muether PS, Bauer J.

Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6548-6553. doi: 10.1167/iovs.16-20128.

PMID:
27918828
20.

Polymeric hepatitis C virus non-structural protein 5A nanocapsules induce intrahepatic antigen-specific immune responses.

Fichter M, Piradashvili K, Pietrzak-Nguyen A, Pretsch L, Kuhn G, Strand S, Knuf M, Zepp F, Wurm FR, Mailänder V, Landfester K, Gehring S.

Biomaterials. 2016 Nov;108:1-12. doi: 10.1016/j.biomaterials.2016.08.046. Epub 2016 Aug 31.

PMID:
27614817
21.

Acute Encephalopathy in Children Associated with Influenza A: A Retrospective Case Series.

Welk A, Schmeh I, Knuf M, Groendahl B, Goebel J, Staatz G, Gawehn J, Gehring S.

Klin Padiatr. 2016 Sep;228(5):280-1. doi: 10.1055/s-0042-111686. Epub 2016 Jul 26. No abstract available.

PMID:
27459719
22.

Viral Infections in Neonates with Suspected Late-Onset Bacterial Sepsis-A Prospective Cohort Study.

Kidszun A, Klein L, Winter J, Schmeh I, Gröndahl B, Gehring S, Knuf M, Weise K, Mildenberger E.

Am J Perinatol. 2017 Jan;34(1):1-7. doi: 10.1055/s-0036-1584150. Epub 2016 May 16.

PMID:
27182999
23.

[Retinal bleeding and venous stasis in a 10-month-old infant after a fall?].

Fieß A, Dithmar S, Kölb-Keerl R, Kunze A, Riße M, Knuf M, Bauer J.

Ophthalmologe. 2016 Aug;113(8):694-8. doi: 10.1007/s00347-015-0188-2. German.

PMID:
26676641
24.

Disease Burden of Rotavirus Gastroenteritis in Children Residing in Germany: A Retrospective, Hospital-based Surveillance.

Kowalzik F, Zepp F, Hoffmann I, Binder H, Lautz D, van Ewijk R, Knuf M, Tenenbaum T, Laass M, Reuter T, Schulze-Rath R, Marron M.

Pediatr Infect Dis J. 2016 Jan;35(1):97-103. doi: 10.1097/INF.0000000000000939.

PMID:
26421806
25.

Inflammatory Characteristics of Monocytes from Pediatric Patients with Tuberous Sclerosis.

Meyer CU, Kurlemann G, Sauter M, Wiemer-Kruel A, Hahn A, Doganci A, Birkholz J, Faber J, Gehring S, Hertzberg C, Zepp F, Knuf M.

Neuropediatrics. 2015 Oct;46(5):335-43. doi: 10.1055/s-0035-1562925. Epub 2015 Sep 10.

PMID:
26356487
26.

[Quadrivalent influenza vaccines].

Wutzler P, Dietz B, Hardt R, Hoins L, Knuf M, Wahle K.

MMW Fortschr Med. 2015 Sep 10;157(15):60-2. doi: 10.1007/s15006-015-3480-9. German. No abstract available.

PMID:
26349732
27.

Dendritic cells change IL-27 production pattern during childhood.

Meyer CU, Birkholz J, Weins N, Doganci A, Gehring S, Zepp F, Knuf M.

BMC Res Notes. 2015 Jun 9;8:232. doi: 10.1186/s13104-015-1182-0.

28.

[Endogenous Candida lens abscess in a premature infant].

Fieß A, Bauer J, Schindel C, Knuf M, Dithmar S.

Ophthalmologe. 2016 Jan;113(1):71-4. doi: 10.1007/s00347-015-0068-9. German.

PMID:
26040792
29.

Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children.

Knuf M, Leroux-Roels G, Rümke H, Rivera L, Pedotti P, Arora AK, Lattanzi M, Kieninger D, Cioppa GD.

Hum Vaccin Immunother. 2015;11(2):358-76. doi: 10.4161/21645515.2014.987014.

30.

Safety and immunogenicity of an MF59-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age.

Knuf M, Leroux-Roels G, Rümke HC, Abarca K, Rivera L, Lattanzi M, Pedotti P, Arora A, Kieninger-Baum D, Della Cioppa G.

Vaccine. 2015 Jan 1;33(1):174-81. doi: 10.1016/j.vaccine.2014.10.085. Epub 2014 Nov 11.

PMID:
25444803
31.

[The polyglandular autoimmune syndrome--quality of life and family clustering].

Hansen MP, Wunderlich SA, Storz SM, Matheis N, Knuf M, Kahaly GJ.

Dtsch Med Wochenschr. 2014 Sep;139(38):1876-82. doi: 10.1055/s-0034-1387214. Epub 2014 Sep 9. German.

PMID:
25203546
32.

4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany.

Eichner M, Schwehm M, Hain J, Uphoff H, Salzberger B, Knuf M, Schmidt-Ott R.

BMC Infect Dis. 2014 Jul 3;14:365. doi: 10.1186/1471-2334-14-365.

33.

Immunogenicity and tolerability of an MF59-adjuvanted, egg-derived, A/H1N1 pandemic influenza vaccine in children 6-35 months of age.

Knuf M, Leroux-Roels G, Rümke HC, Abarca K, Rivera L, Lattanzi M, Pedotti P, Arora A, Kieninger-Baum D, Della Cioppa G.

Pediatr Infect Dis J. 2014 Dec;33(12):e320-9. doi: 10.1097/INF.0000000000000462.

PMID:
24978857
34.

Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany.

Damm O, Eichner M, Rose MA, Knuf M, Wutzler P, Liese JG, Krüger H, Greiner W.

Eur J Health Econ. 2015 Jun;16(5):471-88. doi: 10.1007/s10198-014-0586-4. Epub 2014 May 25.

35.

Pneumococcal vaccination in Europe: schedule adherence.

Gervaix A, Ansaldi F, Brito-Avô A, Azzari C, Knuf M, Martinón-Torres F, Tuerlinckx D, Tin Htar MT, Syrogiannopoulos GA.

Clin Ther. 2014 May;36(5):802-12.e1. doi: 10.1016/j.clinthera.2014.03.001. Epub 2014 Apr 18.

PMID:
24746990
36.

The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study.

Rose MA, Damm O, Greiner W, Knuf M, Wutzler P, Liese JG, Krüger H, Wahn U, Schaberg T, Schwehm M, Kochmann TF, Eichner M.

BMC Infect Dis. 2014 Jan 22;14:40. doi: 10.1186/1471-2334-14-40.

37.

Targeted vaccine selection in influenza vaccination.

Wutzler P, Hardt R, Knuf M, Wahle K.

Dtsch Arztebl Int. 2013 Nov 22;110(47):793-8. doi: 10.3238/arztebl.2013.0793. Review.

38.

The 2009 pandemic influenza A(H1N1) coincides with changes in the epidemiology of other viral pathogens causing acute respiratory tract infections in children.

Gröndahl B, Ankermann T, von Bismarck P, Rockahr S, Kowalzik F, Gehring S, Meyer C, Knuf M, Puppe W.

Infection. 2014 Apr;42(2):303-8. doi: 10.1007/s15010-013-0545-5. Epub 2013 Oct 23.

PMID:
24150959
39.

Detection of respiratory viral infections in neonates treated for suspicion of nosocomial bacterial sepsis: a feasibility study.

Kidszun A, Hansmann A, Winter J, Gröndahl B, Knuf M, Weise K, Mildenberger E.

Pediatr Infect Dis J. 2014 Jan;33(1):102-4. doi: 10.1097/INF.0000000000000008.

PMID:
24064563
40.

The burden of seasonal and pandemic influenza in infants and children.

Ruf BR, Knuf M.

Eur J Pediatr. 2014 Mar;173(3):265-76. doi: 10.1007/s00431-013-2023-6. Epub 2013 May 10.

41.

[Tonsillectomy and tonsillotomy: ENT surgeon and pediatric viewpoints].

Hoppe F, Knuf M.

HNO. 2013 Feb;61(2):173-85; quiz 86. doi: 10.1007/s00106-012-2661-4. German.

PMID:
23407776
42.

Immunogenicity and safety of the quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) in 2-10-year-old children: results of an open, randomised, controlled study.

Knuf M, Romain O, Kindler K, Walther U, Tran PM, Pankow-Culot H, Fischbach T, Kieninger-Baum D, Bianco V, Baine Y, Miller J.

Eur J Pediatr. 2013 May;172(5):601-12. doi: 10.1007/s00431-012-1924-0. Epub 2013 Jan 11.

43.

Validation of a multiplex reverse transcriptase PCR ELISA for the detection of 19 respiratory tract pathogens.

Puppe W, Weigl J, Gröndahl B, Knuf M, Rockahr S, von Bismarck P, Aron G, Niesters HG, Osterhaus AD, Schmitt HJ.

Infection. 2013 Feb;41(1):77-91. doi: 10.1007/s15010-012-0298-6. Epub 2012 Jul 31.

PMID:
22847627
44.

[A rare manifestation of sarcoidosis].

Fieß A, Frisch I, Wicht S, Hofstetter P, Knuf M, Gosepath J, Scheil-Bertram S, Steinhorst UH.

Ophthalmologe. 2012 Aug;109(8):794-7. doi: 10.1007/s00347-012-2594-z. German.

PMID:
22565854
45.

Antibody persistence and immune memory 15 months after priming with an investigational tetravalent meningococcal tetanus toxoid conjugate vaccine (MenACWY-TT) in toddlers and young children.

Knuf M, Baine Y, Bianco V, Boutriau D, Miller JM.

Hum Vaccin Immunother. 2012 Jul;8(7):866-72. doi: 10.4161/hv.20229. Epub 2012 Apr 9.

46.

Antibiotic therapy for pediatric community-acquired pneumonia: do we know when, what and for how long to treat?

Esposito S, Cohen R, Domingo JD, Pecurariu OF, Greenberg D, Heininger U, Knuf M, Lutsar I, Principi N, Rodrigues F, Sharland M, Spoulou V, Syrogiannopoulos GA, Usonis V, Vergison A, Schaad UB.

Pediatr Infect Dis J. 2012 Jun;31(6):e78-85. doi: 10.1097/INF.0b013e318255dc5b. Review.

PMID:
22466326
47.

An assessment of prime-boost vaccination schedules with AS03A -adjuvanted prepandemic H5N1 vaccines: a randomized study in European adults.

Gillard P, Caplanusi A, Knuf M, Roman F, Walravens K, Moris P, Dramé M, Schwarz TF.

Influenza Other Respir Viruses. 2013 Jan;7(1):55-65. doi: 10.1111/j.1750-2659.2012.00349.x. Epub 2012 Mar 9.

48.

The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies.

Ambrose CS, Wu X, Knuf M, Wutzler P.

Vaccine. 2012 Jan 20;30(5):886-92. doi: 10.1016/j.vaccine.2011.11.104. Epub 2011 Dec 7.

49.

Oil-in-water emulsion adjuvant with influenza vaccine in young children.

Vesikari T, Knuf M, Wutzler P, Karvonen A, Kieninger-Baum D, Schmitt HJ, Baehner F, Borkowski A, Tsai TF, Clemens R.

N Engl J Med. 2011 Oct 13;365(15):1406-16. doi: 10.1056/NEJMoa1010331.

50.

Supplemental Content

Support Center